Dover Corp. (DOV) Tops Q1 EPS by 1c; Guides In-Line

Dover Corp. (NYSE: DOV) reported Q1 EPS of $1.94, $0.01 better than the analyst estimate of $1.93. Revenue for the quarter came in at $2.08 billion versus the consensus estimate of $2.07 billion.

GUIDANCE:

Dover Corp. sees FY2023 EPS of $8.85-$9.05, versus the consensus of $8.94. Sees full year revenue growth of 3% to 5%.

For earnings history and earnings-related data on Dover Corp. (DOV) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
• Legence Corp. (LGN) Misses Q2 EPS by 58c